Effects of raloxifene on serum malondialdehyde, erythrocyte superoxide dismutase, and erythrocyte glutathione peroxidase levels in healthy postmenopausal women

dc.contributor.authorKaya, Hakan
dc.contributor.authorÖzkaya, Okan
dc.contributor.authorSezik, Mekin
dc.contributor.authorArslanoğlu, Evrim
dc.contributor.buuauthorYılmaztepe, Arzu
dc.contributor.buuauthorUlukaya, Engin
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı.tr_TR
dc.contributor.researcheridK-5792-2018tr_TR
dc.contributor.scopusid8606136100tr_TR
dc.contributor.scopusid6602927353tr_TR
dc.date.accessioned2022-01-06T08:16:54Z
dc.date.available2022-01-06T08:16:54Z
dc.date.issued2005-03-14
dc.description.abstractObjective: To investigate the relationship between raloxifene administration and serum malondialdehyde (MDA), erythrocyte superoxide dismutase (SOD), erythrocyte glutathione peroxidase (GPx) levels in healthy postmenopausal women. Methods: In a randomized and placebo-controlled design, 80 women received either 60 mg/day raloxifene or placebo for 24 weeks. MDA, SOD, and GPx levels were assessed at 0,4,12, and 24 weeks. Wilcoxon signed-rank test and Mann-Whitney U test were used for comparisons. Results: Six women in the treatment arm and eight women in the placebo group discontinued the study. Mean serum MDA levels were significantly (p = 0.001) decreased from 11.4 nmol/ml at baseline to 8.9 nmol/ml at week 12 with raloxifene treatment. Mean erythrocyte SOD activity was significantly (p = 0.02) reduced from 1472 U/g Hb at baseline to 1173 U/g Hb at week 12 following raloxifene administration. Lowered serum MDA and erythrocyte SOD levels persisted during treatment. On contrary, erythrocyte GPx levels did not change significantly with raloxifene administration. Conclusions: Raloxifene (60 mg/day) lowers serum MDA levels and erythrocyte SOD activity in postmenopausal women after 12 weeks of treatment. The clinical implications of these findings need to be determined.en_US
dc.identifier.citationKaya, H. vd. (2005). "Effects of raloxifene on serum malondialdehyde, erythrocyte superoxide dismutase, and erythrocyte glutathione peroxidase levels in healthy postmenopausal women". Maturitas, 50(3), 182-188.en_US
dc.identifier.endpage188tr_TR
dc.identifier.issn0378-5122
dc.identifier.issn1873-4111
dc.identifier.issue3tr_TR
dc.identifier.pubmed15734599tr_TR
dc.identifier.scopus2-s2.0-13944274553tr_TR
dc.identifier.startpage182tr_TR
dc.identifier.urihttps://doi.org/10.1016/j.maturitas.2004.05.005
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0378512204001744#!
dc.identifier.urihttps://www.maturitas.org/article/S0378-5122(04)00174-4/fulltext
dc.identifier.urihttp://hdl.handle.net/11452/23888
dc.identifier.volume50tr_TR
dc.identifier.wos000227663700005tr_TR
dc.indexed.pubmedPubmeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.collaborationYurt içitr_TR
dc.relation.journalMaturitasen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectGeriatrics & gerontologyen_US
dc.subjectObstetrics & gynecologyen_US
dc.subjectRaloxifeneen_US
dc.subjectSuperoxide dismutaseen_US
dc.subjectGlutathione peroxidaseen_US
dc.subjectMalondialdehydeen_US
dc.subjectAntioxidanten_US
dc.subjectEstrogen-receptor modulatoren_US
dc.subjectCoronary-heart-diseaseen_US
dc.subjectNitric-oxideen_US
dc.subjectOvariectomized ratsen_US
dc.subjectAntioxidant enzymesen_US
dc.subjectIn-vitroen_US
dc.subjectReplacementen_US
dc.subjectBrainen_US
dc.subject.emtreeGlutathione peroxidaseen_US
dc.subject.emtreeMalonaldehydeen_US
dc.subject.emtreeRaloxifeneen_US
dc.subject.emtreeSuperoxide dismutaseen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAgeden_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeClinical trialen_US
dc.subject.emtreeControlled clinical trialen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeDrug effecten_US
dc.subject.emtreeEnzyme activityen_US
dc.subject.emtreeErythrocyteen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeIntermethod comparisonen_US
dc.subject.emtreeNormal humanen_US
dc.subject.emtreePostmenopauseen_US
dc.subject.emtreeProtein expressionen_US
dc.subject.emtreeRandomized controlled trialen_US
dc.subject.emtreeRank sum testen_US
dc.subject.emtreeStatistical analysisen_US
dc.subject.emtreeStatistical significanceen_US
dc.subject.scopusConjugated Estrogens; Diarylpropionitrile; Estradiolen_US
dc.subject.wosGeriatrics & gerontologyen_US
dc.subject.wosObstetrics & gynecologyen_US
dc.titleEffects of raloxifene on serum malondialdehyde, erythrocyte superoxide dismutase, and erythrocyte glutathione peroxidase levels in healthy postmenopausal womenen_US
dc.typeArticle
dc.wos.quartileQ2 (Obstetrics & gynecology)en_US
dc.wos.quartileQ3en_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Yılmaztepe_vd_2005.pdf
Size:
113.72 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: